Suppr超能文献

钙拮抗剂对肾血流动力学和肾小球功能的影响。

Effects of calcium antagonists on renal hemodynamics and glomerular function.

作者信息

Carmines P K, Mitchell K D, Navar L G

机构信息

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana.

出版信息

Kidney Int Suppl. 1992 May;36:S43-8.

PMID:1614067
Abstract

Cytosolic [Ca2+] can be increased by influx of the ion from the extracellular compartment, Ca2+ release from intracellular storage sites, and/or a reduced activity of active transport processes for Ca2+ extrusion or sequestration. Organic calcium antagonists block transmembrane calcium entry and, therefore, can be utilized to evaluate the importance of calcium influx in the regulation of renal hemodynamics. Recent studies indicate that calcium antagonists selectively vasodilate preglomerular arterioles, leading to increases in renal blood flow (RBF), glomerular filtration rate (GFR) and glomerular pressure. In contrast with angiotensin converting enzyme inhibitors and other vasodilator agents, calcium antagonists primarily influence the component of renal vascular resistance responsible for autoregulation, potently attenuating autoregulatory efficiency. Calcium antagonists also block the afferent arteriolar vasoconstriction elicited by angiotensin II, while not influencing the efferent arteriolar vasoconstriction evoked by this peptide. Tubuloglomerular feedback (TGF)-mediated vasoconstrictor responses are also abolished by calcium antagonists, indicating that the TGF effector mechanism may require transmembrane calcium influx into the smooth muscle cells of the afferent arterioles. These observations provide compelling evidence that calcium influx, through pathways which are influenced by organic calcium antagonists, is an integral component of the afferent arteriolar vasoconstriction elicited by a variety of stimuli, while efferent arteriolar vasoconstriction appears to depend on other calcium access pathways.

摘要

胞质内的[Ca2+]可通过离子从细胞外间隙的流入、细胞内储存位点的Ca2+释放和/或Ca2+外排或隔离的主动转运过程活性降低而增加。有机钙拮抗剂可阻断跨膜钙内流,因此可用于评估钙内流在肾血流动力学调节中的重要性。最近的研究表明,钙拮抗剂可选择性地使肾小球前小动脉血管舒张,导致肾血流量(RBF)、肾小球滤过率(GFR)和肾小球压力增加。与血管紧张素转换酶抑制剂和其他血管舒张剂不同,钙拮抗剂主要影响负责自身调节的肾血管阻力成分,有效减弱自身调节效率。钙拮抗剂还可阻断血管紧张素II引起的入球小动脉血管收缩,而不影响该肽引起的出球小动脉血管收缩。钙拮抗剂也可消除管球反馈(TGF)介导的血管收缩反应,这表明TGF效应机制可能需要跨膜钙内流进入入球小动脉的平滑肌细胞。这些观察结果提供了令人信服的证据,即通过受有机钙拮抗剂影响的途径的钙内流是由多种刺激引起的入球小动脉血管收缩的一个组成部分,而出球小动脉血管收缩似乎依赖于其他钙进入途径。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验